Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section
NCT ID: NCT06991985
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
120 participants
OBSERVATIONAL
2025-05-20
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Tourniquet Binding of Cervical on the Blood Volume of Amniotic Fluid in Cesarean Section
NCT06254092
Cesarean Rate in Parturients Without Neuraxial Analgesia
NCT01157325
Immune and Physical Recovery Following Cesarean Delivery
NCT04358757
Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
NCT05333731
The Comparison Of Nerve Blocks In Cesarean Delivery
NCT03333902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Amniotic fluid into the blood group
Enzyme-linked immunosorbent assay
Serum STN and C4 levels were detected
the control group
Enzyme-linked immunosorbent assay
Serum STN and C4 levels were detected
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enzyme-linked immunosorbent assay
Serum STN and C4 levels were detected
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA classification of I-III;
* Age 20-50 years old;
* No previous history of psychiatric diseases or psychotropic drugs;
Exclusion Criteria
* Those with communication difficulties who were unable to complete the screening questionnaire;
20 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Hospital of Shanxi Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zheng Guo
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
yuewei20250520
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.